Pharma & Biotech

For investors in Telix Pharmaceuticals, 2026 is shaping up to be a defining period. The company’s commercial prospects hinge on...

BioNTech's stock has faced significant headwinds from founder transitions and subdued financial forecasts. However, developments within its research pipeline offer...

Investors in biotechnology firm ImmunityBio are navigating a landscape of stark contrasts. The company's commercial prospects appear increasingly bright, driven...

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has...

Danish pharmaceutical giant Novo Nordisk has achieved a landmark regulatory victory with the U.S. Food and Drug Administration (FDA) granting...

The Swiss hearing solutions group Sonova is taking decisive action to refine its business focus. By announcing the sale of...

Tempus AI Inc. finds its equity trading at a critical juncture. The stock reached a new annual low of €36.80...

Bayer's ongoing corporate restructuring is encountering turbulence from two significant external forces. As geopolitical tensions flare and energy costs climb,...

Pharmaceutical giant Pfizer has announced significant progress across two distinct areas of its clinical pipeline, marking a pivotal moment in...

Mirum Pharmaceuticals is entering what could be its most transformative period. The rare disease specialist faces a packed calendar of...